Experimentally-induced exencephaly and spina bifida in mice

Archives of Iranian Medicine

Volumn 5, Issue 3, 2002, Pages 179-183

  Fazel, Alireza ^a   Jalali, Mehdi ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Exencephaly; Morphine; Neural tube; Spina bifida

Indexed keywords

DIAMORPHINE; MORPHINE; OPIATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM MALFORMATION; CONTROLLED STUDY; CYCLOPIA; DATA ANALYSIS; DOSE RESPONSE; EMBRYO; EMBRYOPATHY; EXENCEPHALY; FEMALE; FETUS; FETUS MALFORMATION; FISHER EXACT TEST; GESTATION PERIOD; INCIDENCE; MICROSCOPY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NEWBORN; NONHUMAN; OPIATE ADDICTION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIMORDIUM; SPINA BIFIDA; TERATOGENICITY;

EID: 0036662215     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Shepart T. Human teratology. In: Reed GB, Claireaux AE, eds. Diseases of the Fetus and Newborn: Pathology, Imaging, Genetics, and Management. 2nd ed. New York: Chapman and Hall Medical; 1995: 83-93.
2. Simon E, Hiller J. Opioid peptides and opioid receptors. In: Siegel GJ, Agranoff BW, eds. Basis Neurochemistry: Molecular, Cellular, and Medical Aspects. 5th ed. New York: Raven Press; 1994: 321-339.
3. Dygalo NN, Korani L, Feltsegi K, et al. Effects of morphine and naloxone administered to pregnant rats on the adrenal glands and testes of the offspring. Biull Eksp Biol Med. 1992; 113: 58-60. [In Russian]
4. Eriksson PS, Ronnback L, Effects of prenatal morphine treatment of rats on mortality, bodyweight and analgesic response in the offspring. Drug Alcohol Depend. 1989; 24: 187-94.
5. McMillen IC, Deayton JM. Effects of morphine and naloxone on plasma prolactin concentrations in the fetal sheep and pregnant ewe during late gestation. Neuroendocrinology. 1989; 49: 286-90.
6. Siddiqui A, Haq S, Shah BH. Perinatal exposure to morphine distrusts brain norepinephrine, ovarian cyclicity, and sexual receptivity in rats. Pharmacol Biochem Behav. 1997; 58: 243-8.
7. Silvestre MA, Lucena JE, Roxas R, et al. Effects of timing, dosage, and duration of morphine intake during pregnancy on the amount of morphine in meconium in rat model. Biol Neonate. 1997; 72: 112-7.
8. Geber WF, Schramm IC. Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol. 1975; 123: 705-13.
9. Ornoy A, Michailevskaya V, Lukoshov I, et al. The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. Child Abuse Negl. 1996; 20: 385-96.
10. Sulik KK, Sadler TW. Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies. Ann N Y Acad Sci. 1993; 678: 8-21.
11. Sastry BV. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod Fertil Dev. 1991; 3: 355-72.
12. Hay ED. Cell Biology of Extracellular Matrix. 2nd ed. New York: Plenum Press; 1991.
13. Lodish H, Berk A, Lawrence S. Cell interaction in development. In: Lodish H, ed. Molecular Cell Biology. 4th ed. New York: WH Freeman; 2000: 1004-48.
14. Nasrallah I, Golden JA. Brain, eye, and face defects as a result of ectopic localization of Sonic hedgehog protein in the developing rostral neural tube. Teratology. 2001; 64: 107-13.
15. Zagon IS, Wu Y, McLaughhlin PH. Opioid growth factor and organ development in rat and human embryos. Brain Res. 1999; 839: 313-22.
16. Leslie FM, Chen Y, Winzer-Serhan UH. Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can J Physiol Pharmacol. 1998; 76: 284-93.
17. Ray SB, Wadhwa S. Mu opioid receptors in developing human spinal cord. J Anat. 1999; 195: 11-8.
18. Zhu H, Barr GA. Opioid withdrawal during development: are NMDA receptors indispensable? Trends Pharmacol Sci. 2001; 22: 404-8.
19. Tempel H, Habas J, Paredes W, et al. Morphine-induced down regulation of mu-opioid receptors in neonatal rat brain. Brain Res. 1998; 469: 129-33.
20. Petrov ES, Varlinskaya E, Smotherman WP. Endogeneous mu-opioid systems and perioral responsiveness in the rat fetus. Physiol Behav. 1997; 62: 31-7.
21. Zagon IS, Verderame MF, Zimmers WE, et al. Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse. Brain Res Mol Brain Res. 2000; 84: 106-14.
22. Ekblom P. Extracellular matrix in animal development. Role of extracellular matrix in animal development-an introduction. Experimentia. 1995; 51: 851-2.
23. Pines J, Toldo L, LaFont F. Cell-to-cell contact and extracellular matrix. Web Alert. Curr Opin Cell Biol. 1999; 11: 535-6.
24. Wilkinson D. Meeting report. Neural developments. Mech Dev. 1998; 77: 3-7.
25. Harland R. Neural induction. Curr Opin Gen Dev. 2000; 10: 357-62.
26. DeSesso JM, Scialli AR, Holson JF. Apparent lability of neural tube closure in laboratory animals and humans. Am J Med Genet. 1999; 87: 143-62.
27. Goswami R, Dawson SA, Dawson G. Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-II kappa 7) neurons. J Neurochem. 1998; 70: 1376-82.
28. Hackett DA, Smith JL, Schoenwolf GC. Epidermal ectoderm is required for full elevation and or convergence during lending of the ovian neural plate. Dev Dyn. 1997; 210: 397-406.
29. MacDonald KB, Juriloff D, Harris M. Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology. 1989; 39: 195-13.
30. Mines JH, Cunningham J, Sanes JR. Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol. 1998; 143: 1713-23.
31. Harris M, Juriloff D. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology. 1999; 60: 292-305.